Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense (DoD) to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat. Under the three-year grant, investigators will test the safety and effectiveness of two newly developed antibodies to